🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cardiac Amyloidosis

Echocardiographic Characterization of Cardiac Amyloidosis NCT05760287n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM NCT07690436n/a20 sites📍 Palo Alto📍 Jacksonville📍 Chicago AstraZeneca Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament Biopsy NCT07644325NA1 site📍 Montpellier Clinique Saint Jean, France · Tests: Annular ligament biopsy Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease NCT07154394n/a1 site📍 Essen University Hospital, Essen Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF NCT05577819NA1 site📍 Boston Massachusetts General Hospital · Tests: 99mTc-pyrophosphate Scintigraphy A Study Of MCG In Cardiac Amyloidosis NCT07218705n/a1 site📍 Rochester Mayo Clinic · Tests: SandboxAQ CardiAQ Magnetocardiography DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting NCT07358078n/a27 sites📍 Tucson📍 Beverly Hills📍 La Jolla Alnylam Pharmaceuticals Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis NCT06465810n/a89 sites📍 La Jolla📍 Los Angeles📍 San Francisco AstraZeneca · Tests: Treatment of transthyretin (ATTR) amyloidosis in observational study setting Beta-amyloid PET/CT to Measure Potential Therapeutic Response in AL-CA NCT07829705Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: 11C-PIB, 18F-Florbetapir A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting NCT07235462n/a17 sites📍 Multiple Locations📍 Multiple Locations📍 Multiple Locations Bayer · Tests: Acoramidis (356 mg film-coated tablets) Hybrid Florbetaben PET/MRI for Imaging of Cardiac Amyloidosis NCT07154381n/a1 site📍 Essen University Hospital, Essen Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening) NCT05139797n/a1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: EchoNet-LVH screening for cardiac amyloidosis The Eplontersen Pregnancy and Lactation Outcomes Study NCT07205666n/a1 site📍 Frankfurt AstraZeneca Prevalence of Wild-type TTR Cardiac Amyloidosis in Patients With Polyneuropathy of Unknown Cause. NCT05950867NA1 site📍 Jette Universitair Ziekenhuis Brussel · Tests: ECG + echocardiography, Answering questionnaires Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis NCT06866912n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis NCT07549841Phase 21 site📍 Nantes Nantes University Hospital · Tests: [68Ga]Ga-FAPI-46 A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis. NCT07448623Phase 11 site📍 Groningen Novo Nordisk A/S · Tests: Coramitug Comprehensive Program for Hereditary Transthyretin Amyloidosis NCT07213297n/a1 site📍 Canuelas Hospital de Alta Complejidad en Red · Tests: clinical assessments and complementary examinations Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis NCT04535349NA2 sites📍 Caen📍 Lille University Hospital, Caen · Tests: Whole-body & CZT bone tracer imaging (SPECT) Registre HEAR, Healthcare European Amyloidosis Registry NCT05101304n/a1 site📍 Créteil Saving Lives Matters Swiss Cardiac Amyloidosis REgistry (Swiss-CARE) NCT04776824n/a7 sites📍 Basel📍 Bern📍 Geneva Insel Gruppe AG, University Hospital Bern Study of Acoramidis in Patients With Transthyretin Amyloid Cardiomyopathy NCT07791160n/a1 site📍 Many Locations Bayer · Tests: Acoramidis The Italian Transthyretin Amyloidosis Web-Network NCT05444920n/a30 sites📍 Legnano📍 Orbassano📍 Ancona Fondazione IRCCS Policlinico San Matteo di Pavia Cardiovascular Multimodality Imaging Study NCT06610019n/a1 site📍 The Bronx Montefiore Medical Center Liver and Coagulation Disorders in Cardiac Transthyretin Amyloidosis NCT07766135n/a1 site📍 Messina University of Messina BE.Amycon Biobank & Data Registry UZ Leuven NCT07172243n/a2 sites📍 Leuven📍 Leuven Universitaire Ziekenhuizen KU Leuven Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy NCT06634108Phase 1, Phase 21 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Genistein [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis NCT07232459n/a3 sites📍 Hefei📍 Qingdao📍 Tianjin Tianjin Medical University · Tests: [18F]FT8 [64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy NCT07560306Phase 31 site📍 Boston Brigham and Women's Hospital · Tests: [64Cu]FBP8 PET/MR A Phase 3 Study of NTLA-2001 in ATTRv-PN NCT06672237Phase 314 sites📍 Buenos Aires📍 Buenos Aires📍 San Juan Bautista Intellia Therapeutics · Tests: nexiguran ziclumeran, Normal Saline as Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy